Corcept Therapeutics

Corcept Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative drugs to treat serious disorders related to cortisol, a hormone that plays a pivotal role in the body’s stress response. Our mission is to improve the lives of patients who suffer from conditions associated with excessive cortisol, including Cushing's syndrome and major depressive disorder. Founded in 1998, our team of experienced professionals is committed to advancing our proprietary technology and delivering effective therapeutics to those in need. We leverage our expertise in cortisol modulation to design treatments that improve patient outcomes and enhance quality of life.